Oral pyogenic granulomas show MAPK/ERK signaling pathway activation, which occurs independently of BRAF, KRAS, HRAS, NRAS, GNA11, and GNA14 mutations
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Federal de Minas Gerais
Descrição
Tipo
Artigo de periódico
Título alternativo
Primeiro orientador
Membros da banca
Resumo
Background: Pyogenic granuloma (PG) is a benign nodular lesion with a prominent vascular component which may affect different sites. Recently, BRAF, KRAS, HRAS, NRAS, GNA11, and GNA14 mutations were reported on PGs of the skin. The present study assessed the role of the MAPK/ERK pathway in oral PG pathogenesis.
Methods: Mutations in hotspot regions of genes involved in the MAPK/ERK pathway activation were investigated by Sanger sequencing. The expression of phospho-ERK1/2 was evaluated by immunohistochemistry.
Results: Oral PGs did not show mutations in the sequenced regions of the genes BRAF, KRAS, HRAS, NRAS, GNA11, or GNA14. Our results also showed activation of the MAPK/ERK pathway demonstrated by phospho-ERK1/2 immunohistochemical positivity.
Conclusions: Although oral PG shows MAPK/ERK pathway activation, the driver molecular event remains to be elucidated.
Abstract
Assunto
Mitogen-activated protein kinases, Hemangioma, capillary, Oncogenes, Granuloma, pyogenic, Genes, Immunohistochemistry, Mitogen-activated protein kinase kinases
Palavras-chave
MAPK, RAS, Capillary hemangioma, Oncogene, Pyogenic granuloma
Citação
Curso
Endereço externo
https://onlinelibrary.wiley.com/doi/10.1111/jop.12922